Nakhlé, Gisèle http://orcid.org/0000-0002-0182-578X
Tardif, Jean-Claude
Roy, Denis
Rivard, Léna
Samuel, Michelle
Dubois, Anick
LeLorier, Jacques
Funding for this research was provided by:
Institut de Cardiologie de Montréal
Health Collaboration Acceleration Fund (FACS) - Government of Quebec
Article History
Accepted: 11 January 2023
First Online: 31 January 2023
Declarations
:
: This work was supported by the Montreal Heart Institute. The Montreal Heart Institute received funding from the Health Collaboration Acceleration Fund (FACS) from the Government of Quebec.
: Drs. G. Nakhlé and J. LeLorier have received Grants from the Montreal Heart Institute for this project. The Montreal Heart Institute received funding from the Health Collaboration Acceleration Fund (FACS) from the Government of Quebec. Drs. D. Roy, M. Samuel, and A. Dubois have no relevant financial or non-financial interests to disclose. Dr. J-C. Tardif reports Grants from Amarin, Grants and personal fees from AstraZeneca, Grants, personal fees, and other from Dalcor, Grants from Esperion, Grants from Ionis, Grants and personal fees from Sanofi, Grants and personal fees from Servier, Grants from RegenXBio, Grants from Novartis, Grants and personal fees from Pfizer, personal fees from HLS Pharmaceuticals, personal fees from Pendopharm, outside the submitted work. In addition, Dr. Tardif has a patent “Genetic markers for predicting responsiveness to therapy with hdl-raising or hdl mimicking agent” pending, a patent “Methods for using low dose colchicine after myocardial infarction” pending (invention assigned to the Montreal Heart Institute), a patent “Methods of treating a coronavirus infection using Colchicine” pending, and a patent “Early administration of low-dose colchicine after myocardial infarction" pending. Dr. L. Rivard reports Grants from Bayer Inc. during the conduct of the study and Grants from the Montreal Heart Institute Foundation, the Heart and Stroke Foundation of Canada, and the Canadian Institutes of Health Research (CHIR) outside the submitted work.
: Not applicable.
: Not applicable.
: Not applicable.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author upon reasonable request.
: Not applicable.
: All persons who meet authorship criteria are listed as authors and all authors certify that they have approved the version of the manuscript to be published and take responsibility for the content of the manuscript.
: GN: Ideas, formulation of research question, statement of hypothesis, development and design of methodology, creation of models, programming and statistical analysis, data collection, writing the initial draft, and finalizing manuscript for publication. J-CT and AD: Funding acquisition, critical review, commentary, and revisions. DR, LR, and MS: Critical review, commentary, and revisions. JL: Ideas, supervising of research, funding acquisition, critical review, commentary, and revisions.